Berger Financial Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Berger Financial Group's IBB Position: Q3 2026 in Review
Berger Financial Group reduced its iShares Biotechnology ETF (IBB) stake by 2.2% in Q3 2026, selling an estimated $10.4K and leaving 2,312 shares worth $487K. The position accounts for 0.02% of the portfolio, ranked #312.
Berger Financial Group first reported a position in IBB in Q4 2020 and has held it in 19 quarters since. The position peaked at $640K in Q2 2021. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Berger Financial Group held 2,312 shares of iShares Biotechnology ETF worth $487K as of Q3 2026.
- Berger Financial Group sold 52 iShares Biotechnology ETF shares in Q3 2026, an estimated $10.4K.
- iShares Biotechnology ETF made up 0.02% of Berger Financial Group's portfolio in Q3 2026, its #312 holding.
- Berger Financial Group first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 19 quarters since.
- Berger Financial Group's iShares Biotechnology ETF position peaked at $640K in Q2 2021.
- 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Berger Financial Group's 13F filing for Q3 2026, filed 10 Nov 2026.